Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an announcement.
Pharmaxis Ltd has released a shareholder update for the March quarter, focusing on its subsidiary, Syntara. The update includes forward-looking statements about Syntara’s future financial position and the potential of its products. However, it cautions that actual results may differ due to various risks and uncertainties, and there is no guarantee of success in developing or partnering products in their pipeline.
More about Pharmaxis Ltd
YTD Price Performance: -38.75%
Average Trading Volume: 3,589,326
Technical Sentiment Signal: Buy
Current Market Cap: A$79.58M
Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.